跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
周 宗慶
Doctor
外科部
電子郵件
n041221
mail.hosp.ncku.edu
tw
h-index
232
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2025
每年研究成果
概覽
指紋
網路
研究成果
(20)
類似的個人檔案
(6)
指紋
查看啟用 Tsung-Ching Chou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Living Donor
100%
Kidney Graft
75%
Allograft
61%
Hepatocellular Carcinoma
50%
Nephrectomy
50%
Effective Kidney Plasma Flow
50%
Surgical Technique
41%
Recurrent Disease
40%
Renal Artery
33%
Neoplasm
30%
Kidney Transplantation
27%
Glomerular Filtration Rate
25%
Liver Transplantation
25%
HLA Antibody
25%
Enzyme Linked Immunosorbent Assay
25%
Portal Vein Blood Flow
25%
Splenectomy
25%
Hemodynamic
25%
Autophagy
25%
Virus
25%
Tumor Recurrence
25%
Contraindication
25%
Artery Ligation
25%
Peliosis Hepatis
25%
Ascites
25%
Reticulin
25%
Liver Dysfunction
25%
Peroperative Complication
19%
Bovine Serum Albumin
17%
Creatinine
16%
Kidney Function
16%
Overall Survival
15%
Recurrence Free Survival
15%
Artery Reconstruction
14%
Laparoscopic Surgery
12%
Hyperbilirubinemia
12%
Sinusoid
12%
Liver Graft
12%
Needle Biopsy
12%
Multivariate Analysis
9%
Thrombosis
8%
Necrosis
8%
Postoperative Complication
8%
Learning Curve
8%
Bleeding
8%
Ischemia
8%
Survival Rate
8%
Graft Survival
8%
Body Surface
7%
Hazard Ratio
6%
Keyphrases
NASH-related HCC
25%
Kidney Transplantation
25%
Gallstone Disease
25%
HLA Antibodies
25%
Enzyme-linked Immunosorbent Assay (ELISA)
25%
Cross-matching
25%
Antibody Analysis
25%
Recipient Outcomes
25%
Living Kidney Donor
25%
Donor Nephrectomy
25%
Hepatitis B Virus Recurrence
25%
Graft Inflow Modulation
25%
Statin Use
25%
Meta-analysis
25%
Graft Function
25%
Short-term Outcomes
25%
Kidney Transplant Recipients
25%
Living Donor Kidney Transplantation
25%
Peliosis Hepatis
25%
Massive Ascites
25%
Effective Renal Plasma Flow
25%
Cholecystectomy
25%
Kidney Graft Survival
25%
Liver Microenvironment
25%
Isoagglutinin Titer
25%
Cellcept
25%
Cyclosporine
25%
Tacrolimus
25%
Myfortic
25%
Disease Prevention
16%
Centers for Disease Control
16%
Graft Survival
15%
Mycophenolic Acid Levels
15%
Odds Ratio
13%
Confidence Interval
13%
Statins
13%
Lambda
12%
Reticulin
12%
Liver Transplantation
12%
Reticulin Fiber
12%
Last Resort
12%
Laparoscopy
12%
Guided Biopsy
12%
Centrilobular
12%
Multiple Nodules
12%
Offending Drugs
12%
Hyperbilirubinemia
12%
Core Needle Biopsy
12%
Kidney Transplant
12%
Peliosis
12%
Immunology and Microbiology
HLA Antibody
50%
Liver Transplantation
50%
Enzyme-Linked Immunosorbent Assay
31%
Kidney Transplantation
25%
Hepatitis B
25%
Immune Escape
25%
Hepatitis B Virus
25%
Effective Kidney Plasma Flow
25%
Hemodynamic
25%
Portal Vein Blood Flow
25%
Artery
25%
Bovine Serum Albumin
17%
HBsAg
15%
Hepatitis B Antigen
15%
Glomerulus Filtration
14%
Plasmapheresis
9%
Surface Area
7%
Body Surface
7%
Kidney Function
7%
Allograft
5%
